SEC Form 4 · accession 0001144204-17-033909
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BFI Co., LLC
10% Owner
Period of report
Jun 21, 2017
Accepted (ET)
Jun 23, 2017 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 21, 2017 | C | 48,000 | $0.00 | A | 96,000 | D | |
| Class A Common StockF2,F3 | Jun 21, 2017 | S | 16,000 | $37.17 | D | 80,000 | D | |
| Class A Common StockF2,F4 | Jun 22, 2017 | S | 16,000 | $37.19 | D | 64,000 | D | |
| Class A Common StockF2,F5 | Jun 23, 2017 | S | 16,000 | $37.10 | D | 48,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1 | $0.00 | Jun 21, 2017 | C | 48,000 | D | — | — | Class A Common Stock | 48,000 | 20,670,836 | D |
Explanation of responses
- F1Class B Common Stock is convertible into Class A Common Stock at any time after issuance on a one-for-one basis, and has no expiration date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2016.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.40, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $37.65, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.65, inclusive.